These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

387 related items for PubMed ID: 24300740

  • 21. Pathogenesis and management of irritable bowel syndrome.
    Mathew P, Bhatia SJ.
    Trop Gastroenterol; 2009; 30(1):19-25. PubMed ID: 19624083
    [Abstract] [Full Text] [Related]

  • 22. Constella™(EU)-Linzess™(USA): the last milestone in the long journey of the peptide linaclotide and its implications for the future of peptide drugs.
    Góngora-Benítez M, Tulla-Puche J, Albericio F.
    Future Med Chem; 2013 Mar; 5(3):291-300. PubMed ID: 23464519
    [Abstract] [Full Text] [Related]

  • 23. Clinical trial: phase 2 study of lubiprostone for irritable bowel syndrome with constipation.
    Johanson JF, Drossman DA, Panas R, Wahle A, Ueno R.
    Aliment Pharmacol Ther; 2008 Apr; 27(8):685-96. PubMed ID: 18248656
    [Abstract] [Full Text] [Related]

  • 24. Randomised clinical trials: linaclotide phase 3 studies in IBS-C - a prespecified further analysis based on European Medicines Agency-specified endpoints.
    Quigley EM, Tack J, Chey WD, Rao SS, Fortea J, Falques M, Diaz C, Shiff SJ, Currie MG, Johnston JM.
    Aliment Pharmacol Ther; 2013 Jan; 37(1):49-61. PubMed ID: 23116208
    [Abstract] [Full Text] [Related]

  • 25. A randomised controlled trial assessing the efficacy and safety of repeated tegaserod therapy in women with irritable bowel syndrome with constipation.
    Tack J, Müller-Lissner S, Bytzer P, Corinaldesi R, Chang L, Viegas A, Schnekenbuehl S, Dunger-Baldauf C, Rueegg P.
    Gut; 2005 Dec; 54(12):1707-13. PubMed ID: 16020489
    [Abstract] [Full Text] [Related]

  • 26. Effects of linaclotide in patients with irritable bowel syndrome with constipation or chronic constipation: a meta-analysis.
    Videlock EJ, Cheng V, Cremonini F.
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1084-1092.e3; quiz e68. PubMed ID: 23644388
    [Abstract] [Full Text] [Related]

  • 27. Clinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome--results of two randomized, placebo-controlled studies.
    Drossman DA, Chey WD, Johanson JF, Fass R, Scott C, Panas R, Ueno R.
    Aliment Pharmacol Ther; 2009 Feb 01; 29(3):329-41. PubMed ID: 19006537
    [Abstract] [Full Text] [Related]

  • 28. Lubiprostone (Amitiza) for irritable bowel syndrome with constipation.
    Med Lett Drugs Ther; 2008 Jul 14; 50(1290):53-4. PubMed ID: 18617872
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Lubiprostone for the treatment of adults with constipation and irritable bowel syndrome.
    Schey R, Rao SS.
    Dig Dis Sci; 2011 Jun 14; 56(6):1619-25. PubMed ID: 21523369
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. New pharmacological treatment options for irritable bowel syndrome with constipation.
    Nusrat S, Miner PB.
    Expert Opin Emerg Drugs; 2015 Jun 14; 20(4):625-36. PubMed ID: 26548544
    [Abstract] [Full Text] [Related]

  • 39. Pharmacologic treatment of constipation: what is new?
    Pohl D, Tutuian R, Fried M.
    Curr Opin Pharmacol; 2008 Dec 14; 8(6):724-8. PubMed ID: 18687411
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.